Not applicableStudy completedNCT00918892What this trial is testingAssessment of Candidate Protein Expression in Breast Cancer SpecimensWho this might be right forBreast Cancer Case Comprehensive Cancer Center 460
Large-scale testing (Phase 3)Study completedNCT01702571What this trial is testingTrastuzumab Emtansine in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer Who Have Received Prior Anti-HER2 And Chemotherapy-based TreatmentWho this might be right forBreast Cancer Hoffmann-La Roche 2,185
Early research (Phase 1)Looking for participantsNCT06533332What this trial is testingTrial of ERX-315 in Participants With Advanced Solid TumorsWho this might be right forAdvanced Solid TumorMetastatic Breast CancerMetastatic Ovarian Cancer+3 more EtiraRx Australia Pty Ltd 36
Early research (Phase 1)Study completedNCT03096054What this trial is testingA Phase I Trial of LY3143921 Hydrate in Solid TumoursWho this might be right forColorectal CancerHigh Grade Serous Ovarian CancerNon Small-cell Lung Cancer (Squamous Cell Variant)+4 more Cancer Research UK 69
Early research (Phase 1)Study completedNCT01286987What this trial is testingStudy of Talazoparib, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid TumorsWho this might be right forAdvanced or Recurrent Solid TumorsBreast NeoplasmsOvarian Cancer, Epithelial+4 more Pfizer 113
Testing effectiveness (Phase 2)Ended earlyNCT00558545What this trial is testingA Phase 1-2, XIAP Antisense AEG35156 With Weekly Paclitaxel in Patients With Advanced Breast CancerWho this might be right forHuman Mammary Carcinoma Aegera Therapeutics 61
Not applicableUnknownNCT01850628What this trial is testingNSABP Biospecimen Discovery ProjectWho this might be right forBreast Cancer NSABP Foundation Inc 50
Large-scale testing (Phase 3)Study completedNCT01935492What this trial is testing8 Continuous vs 8 Intermittent Cycles in First and Second Line in HER2/Neu Neg Metastatic Breast CancerWho this might be right forHuman Epidermal Growth Factor 2 Negative Carcinoma of BreastMetastatic Breast Cancer Borstkanker Onderzoek Groep 420
Not applicableEnded earlyNCT00358098What this trial is testingStudy to Determine the Utility of FES-PET and FDG-PET in the Prediction of Response to Hormone Therapy in Women With Estrogen Positive Metastatic Breast CancerWho this might be right forMetastatic Breast Cancer AHS Cancer Control Alberta 51
Not applicableStudy completedNCT04460898What this trial is testingRW Treatment Patterns and Outcomes in Postmenopausal HR+/HER2- mBC Patients Treated With Palbociclib Plus Letrozole as Initial Endocrine Therapy at Community Oncology Practices in the U.S.Who this might be right forBreast Cancer Pfizer 195
Early research (Phase 1)Ended earlyNCT02964507What this trial is testingDose Escalation and Expansion Study of GSK525762 in Combination With Fulvestrant in Participants With Hormone Receptor-positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Advanced or Metastatic Breast CancerWho this might be right forNeoplasms GlaxoSmithKline 124
Large-scale testing (Phase 3)Study completedNCT01566721What this trial is testingA Safety and Tolerability Study of Assisted and Self-Administered Subcutaneous (SC) Herceptin (Trastuzumab) as Adjuvant Therapy in Early Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast CancerWho this might be right forBreast Neoplasms Hoffmann-La Roche 2,577
Large-scale testing (Phase 3)Looking for participantsNCT04263298What this trial is testingFulvestrant Versus Capecitabine as Maintenance Therapy After First-line Chemotherapy in Patients With HR+/HER2- Metastatic Breast CancerWho this might be right forMetastatic Breast Cancer Herui Yao 210
Not applicableStudy completedNCT01000246What this trial is testingResponse to Influenza Virus Vaccination in Patients Immunocompromised Due to ChemotherapyWho this might be right forMamma CarcinomaHeart Failure St. Antonius Hospital 50
Early research (Phase 1)Ended earlyNCT03816839What this trial is testingEvaluation of Orally Administered Amcenestrant (SAR439859) in Japanese Postmenopausal Patients With Advanced Breast Cancer (AMEERA-2)Who this might be right forBreast Cancer Sanofi 10
Early research (Phase 1)Looking for participantsNCT05304962What this trial is testingFIH Study of RGT-419B Alone and With Endocrine Therapy in HR-Positive, HER2-Negative Advanced/Metastatic Breast CancerWho this might be right forBreast Cancer Regor Pharmaceuticals Inc. 64
Testing effectiveness (Phase 2)Looking for participantsNCT07427394What this trial is testingStudy to Evaluate the Safety and Tolerability of Camizestrant in Combination With Atirmociclib in Women With Advanced Breast CancerWho this might be right forAdvanced Breast Cancer AstraZeneca 24
Not applicableAvailableNCT04091295What this trial is testingBLESSED: Expanded Access for DNG64-CAR-V for Advanced Pancreatic Cancer, Sarcoma and Carcinoma of BreastWho this might be right forPancreatic CancerOsteosarcomaMPNST (Malignant Peripheral Nerve Sheath Tumor)+6 more Aveni Foundation
Not applicableStudy completedNCT02954471What this trial is testingStudy of Human Epidermal Growth Factor Receptor 2 (HER2) Expression in Participants With Early/Metastatic Breast Cancer in Saudi ArabiaWho this might be right forBreast Cancer Hoffmann-La Roche 351
Not applicableStudy completedNCT02921191What this trial is testingDescriptive Analysis of G-CSF Use in Patients With Breast Cancer, Lung Cancer, or Lymphoma TreatedWho this might be right forBreast CancerLung Cancer Biologics & Biosimilars Collective Intelligence Consortium 57,725